Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung Disorders

NCT02946658 · Status: SUSPENDED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-09-12

No results posted yet for this study

Summary

Chronic Obstructive Pulmonary Disease (COPD) is a lung-related disorder that is characterized by long-term, often progressive state of poor airflow. Primary symptoms include low oxygen tension, shortness of breath, productive cough, and broncho-pulmonary inflammation and interference with oxygen-carbon dioxide exchange.

Air pollution and tobacco smoking are felt to be the most common cause of these issues. Diagnostic testing is based on poor airflow measured by lung function studies and whose symptoms do not improve much with antiasthma bronchodilators.

Study is an interventional study to document the safety and efficacy of use of AD-cSVF in chronic broncho-pulmonary disease groups.

Conditions

Interventions

PROCEDURE

lipoaspiration

Closed syringe harvesting subdermal fat

PROCEDURE

ADcSVF

Isolation of AD-cSVF

PROCEDURE

Normal Saline IV

Normal Saline IV containing AD-cSVF

Sponsors & Collaborators

  • Terry, Glenn C., M.D.

    collaborator INDIV
  • Healeon Medical Inc

    lead INDUSTRY

Principal Investigators

  • Robert W Alexander, MD · Healeon Medical Inc

  • Glenn C. Terry, MD · Global Alliance for Regenerative Medicine (GARM)

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2026-08-14
Completion
2027-08-14

Countries

  • United States
  • Honduras

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02946658 on ClinicalTrials.gov